Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $517,649 - $703,800
7,500 New
7,500 $527 Million
Q4 2023

Feb 13, 2024

BUY
$76.22 - $98.51 $571,650 - $738,825
7,500 New
7,500 $723 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Flow State Investments, L.P. Portfolio

Follow Flow State Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flow State Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Flow State Investments, L.P. with notifications on news.